Tirofiban - Medicure/Merck & Co
At a glance
- Drug Originator Merck & Co
- Drug Licenced by 4P Therapeutics; AOP Orphan Pharmaceuticals AG; Aspen Pharmacare; Cipher Pharmaceuticals; Correvio Pharma; Eddingpharm; Iroko Pharmaceuticals; Medicure; MGI GP; Mitsubishi Tanabe Pharma Europe; Seyer Pharmatec; Teson Pharma; Verity Pharmaceuticals; ZAO Firm EUROSERVICE
- Drug Class Anti-ischaemics; Anticoagulants; Antihaemorrhagics; Antithrombotics; Antivirals; Aromatic amino acids; Cardiovascular therapies; Ischaemic heart disorder therapies; Piperidines; Small molecules; Sulfonamides; Vascular disorder therapies
- Mechanism of Action GPIIb-IIIa antagonists
- USA Patent Applicants MEDICURE
- USA Patents 9
- NDAs 2
- Patent Applications 4,368
Table of Contents
Disclaimer